Stem Cell Therapy for Lung Cancer: A New Hope Entering Human Trials

HPX24h > Science > Stem Cell Therapy for Lung Cancer: A New Hope Entering Human Trials

Stem cell therapy combined with gene therapy is emerging as one of the promising breakthroughs in the treatment of lung cancer, a disease with a high mortality rate and difficult to treat. Researchers are currently conducting trials of this therapy on humans, opening up a new opportunity for lung cancer patients, who often have to choose between traditional treatments such as chemotherapy and radiation.

This therapy uses stem cells from bone marrow, which are genetically modified to carry an anti-cancer gene called TRAIL. This gene, when implanted into the stem cells, has the ability to kill cancer cells without harming healthy tissues. The method not only helps protect the gene from degradation in the body but also can activate a special signaling pathway to destroy cancer cells within the tumor. According to Dr. James Larkin, the lead researcher at the London Cancer Research Centre: “Using stem cells carrying the TRAIL gene is an important step forward, helping to enhance the ability to kill cancer cells while protecting the body from the severe side effects of chemotherapy.” (BBC News, 2024)

This research has been funded by the Medical Research Council (MRC) with a grant of £2 million (3 million USD). Clinical trials are planned to begin this year, to test the safety of stem cell therapy in humans, before progressing to trials on 56 lung cancer patients. These trials will compare stem cell therapy combined with chemotherapy to traditional treatment methods.

One of the notable results from early animal trials was a significant reduction in tumor size, and in some cases, tumors completely disappeared. “We are very optimistic about the potential of stem cell therapy in reducing tumor size, and we hope the results in humans will be equally successful,” Dr. Larkin shared in an interview with BBC News in 2024.

“Stem cell therapy not only offers hope for lung cancer patients but could also open up treatment opportunities for many other types of cancer in the future.”
Dr. James Larkin, London Cancer Research Centre, BBC News, 2024.

These trials will be conducted at the National Health Service (NHS), where doctors and medical experts will closely monitor the body’s response to stem cell therapy. The initial goal is to ensure the safety of the method, followed by evaluating the effectiveness of combining stem cell therapy with chemotherapy. Experts hope that this approach will provide a new treatment option for lung cancer patients, minimizing the side effects of chemotherapy and improving treatment outcomes.

“If successful, stem cell gene therapy could become a standard treatment method for lung cancer.” – Dr. James Larkin, London Cancer Research Centre, BBC News, 2024.

These stem cell and gene therapy studies not only open up a new method for treating cancer but also offer hope for patients who no longer have viable treatment options. This breakthrough could change the way we treat lung cancer and other cancers in the future.

Human trials this year will be an important milestone in the development of stem cell therapy for lung cancer treatment. If proven effective, this method could offer millions of lung cancer patients worldwide a new chance at life, while also opening a new chapter in the application of biotechnology and stem cells in advanced treatment therapies.